title: Clinical inquiries. Does screening for microalbuminuria in diabetes prevent complications?
authors.affiliation: Moses Cone Health System Family Practice Residency, Greensboro, NC, USA.
authors.forename: Wayne A
authors.initials: WA
authors.lastname: Hale
authors.forename: Joan
authors.initials: J
authors.lastname: Nashelsky
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Wilson
mesh_terms: D000419:Albuminuria / Q000175:diagnosis*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D008403:Mass Screening / Q000379:methods; D016032:Randomized Controlled Trials as Topic
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents